Michael Engsig
Vorstandsvorsitzender bei NYKODE THERAPEUTICS
Vermögen: 22 761 $ am 30.06.2024
Ursprung des Netzwerks ersten Grades von Michael Engsig
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 30 | |
| Public Company | Pharmaceuticals: Major | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michael Engsig
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ENKAM Pharmaceuticals A/S
 ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | Medical Specialties | Chief Executive Officer | |
Front Baldur, Inc.
 Front Baldur, Inc. Marine ShippingTransportation Part of SFL Corp. Ltd., Front Baldur, Inc. operates private ships. | Marine Shipping | Director/Board Member | |
Front Heimdall, Inc.
 Front Heimdall, Inc. Financial ConglomeratesFinance Part of SFL Corp. Ltd., Front Heimdall, Inc. provides financial services to the ship industry. | Financial Conglomerates | Director/Board Member | |
SFL Ace 1 Co. Ltd.
 SFL Ace 1 Co. Ltd. Financial ConglomeratesFinance Part of SFL Corp. Ltd., SFL Ace 1 Co. Ltd. is a Bermudian company that provides investment and financial services. The company is located in Bermuda. | Financial Conglomerates | Director/Board Member | |
SFL Ace II Co. Ltd.
 SFL Ace II Co. Ltd. Marine ShippingTransportation Part of SFL Corp. Ltd., SFL Ace II Co. Ltd. is a Bermudian company that operates crude oil tankers. The company is located in Bermuda. | Marine Shipping | Director/Board Member | |
SFL Avon, Inc.
 SFL Avon, Inc. Marine ShippingTransportation Part of SFL Corp. Ltd., SFL Avon, Inc. operates crude oil tankers. | Marine Shipping | Director/Board Member | |
SFL Dee, Inc.
 SFL Dee, Inc. Marine ShippingTransportation Part of SFL Corp. Ltd., SFL Dee, Inc. operates crude oil tankers. | Marine Shipping | Director/Board Member | |
SFL Golden Island Ltd.
 SFL Golden Island Ltd. Marine ShippingTransportation Part of SFL Corp. Ltd., SFL Golden Island Ltd. is a Bermudian company that operates crude oil tankers. | Marine Shipping | Director/Board Member | |
SFL Golden Straits Ltd.
 SFL Golden Straits Ltd. Marine ShippingTransportation Part of SFL Corp. Ltd., SFL Golden Straits Ltd. is a Bermudian company that operates crude oil tankers. | Marine Shipping | Director/Board Member | |
SFL Humber, Inc.
 SFL Humber, Inc. Marine ShippingTransportation Part of SFL Corp. Ltd., SFL Humber, Inc. operates crude oil tankers. The company is based in Oslo, Norway. | Marine Shipping | Director/Board Member | |
SFL Tamar, Inc.
 SFL Tamar, Inc. Marine ShippingTransportation Part of SFL Corp. Ltd., SFL Tamar, Inc. operates crude oil tankers. | Marine Shipping | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PHOTOCURE ASA | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Director/Board Member | |
| BIOPORTO A/S | Medical Specialties | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| Karolinska Institutet | College/University | Director/Board Member Undergraduate Degree | |
| PHARMA EQUITY GROUP A/S | Real Estate Development | Chairman Director/Board Member | |
| Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
| University of Uppsala | College/University | Doctorate Degree Undergraduate Degree | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Technical University of Denmark | College/University | Doctorate Degree Doctorate Degree | |
| WEIFA ASA | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| University of Oslo | College/University | Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
| Norwegian School of Economics & Business Administration | College/University | Graduate Degree Graduate Degree | |
| Norwegian University of Science & Technology | College/University | Doctorate Degree Graduate Degree | |
| BI Norwegian Business School | College/University | Undergraduate Degree Undergraduate Degree | |
| FLEX LNG LTD. | Marine Shipping | Director of Finance/CFO | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Chief Executive Officer | |
| Combio A/S | Founder | ||
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Chairman | |
Nextera AS
 Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Director of Finance/CFO President | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer General Counsel | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
FLEX LNG Management Ltd.
 FLEX LNG Management Ltd. Oil & Gas ProductionEnergy Minerals FLEX LNG Management Ltd. engages in the provision of management services to FLEX LNG Ltd. It renders general administration and contract management. The company is headquartered in London, the United Kingdom. | Oil & Gas Production | Director of Finance/CFO | |
Legemiddelindustrien
 Legemiddelindustrien Pharmaceuticals: MajorHealth Technology Legemiddelindustrien provides pharmaceutical industry services. The private company is based in Oslo, Norway. | Pharmaceuticals: Major | Chairman Director/Board Member | |
InnoCC ApS
 InnoCC ApS Medical SpecialtiesHealth Technology InnoCC ApS manufactures and develops medical devices for critical care units, which measure heart and lung function non-invasively on the basis of gas exchange in the lungs. It also develops devices and modules for non-invasive measurement of cardiac output, oxygen uptake, and functional residual capacity. The company was founded in 2014 and is headquartered in Odense, Denmark. | Medical Specialties | Chairman Chief Executive Officer | |
JGN 1 3-12-2018 ApS
 JGN 1 3-12-2018 ApS Medical SpecialtiesHealth Technology JGN 1 3-12-2018 ApS develops and manufactures medical devices. Its products include Innocor, an instrument measuring cardiac output non-invasively; and AMIS 2000 The company is headquartered in Glamsbjerg, Denmark. | Medical Specialties | Chairman Director/Board Member | |
Bioinnovation Institute
 Bioinnovation Institute Miscellaneous Commercial ServicesCommercial Services Part of Novo Nordisk A/S, Bioinnovation Institute is a Danish company that offers entrepreneurs and researchers in life science. The company is based in Copenhagen, Denmark. The CEO of the company is Jens Nielsen. | Miscellaneous Commercial Services | Consultant / Advisor Director/Board Member | |
Flex LNG Management AS
 Flex LNG Management AS Miscellaneous Commercial ServicesCommercial Services Part of FLEX LNG Ltd., Flex LNG Management AS is a Norwegian company that provides administrative services. The company is based in Oslo, Norway. Øystein Moksheim Kalleklev has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| Gurvinvest AS | Director/Board Member |
Statistik
International
| Dänemark | 19 |
| Norwegen | 14 |
| Bermuda | 11 |
| Schweden | 5 |
| Vereinigtes Königreich | 4 |
Sektoral
| Health Technology | 19 |
| Transportation | 10 |
| Consumer Services | 10 |
| Finance | 7 |
| Commercial Services | 6 |
Operativ
| Director/Board Member | 293 |
| Corporate Officer/Principal | 91 |
| Chairman | 73 |
| Treasurer | 51 |
| Chief Executive Officer | 49 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Harald Gurvin | 98 |
| Anne Michelle Whitaker | 35 |
| Einar Jørgen Greve | 34 |
| Peter Morch Eriksen | 32 |
| Ole Larsen | 32 |
| Alf Gunnar Martin Nicklasson | 31 |
| Bernd Seizinger | 23 |
| Shomit Ghose | 23 |
| Morten Albrechtsen | 23 |
| Mats Johan Peter Thorén | 23 |
| Martin N. Bonde | 22 |
| Tom Edward Pike | 20 |
| Lars Lund-Roland | 19 |
| Elaine Sullivan | 15 |
| Birgitte Volck | 13 |
- Börse
- Insiders
- Michael Engsig
- Unternehmensverbindungen
